Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Family Medicine
Glaucoma Clinical Trials
A listing of Glaucoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Arizona
Phoenix :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Arkansas
Fayetteville : Vold Vision, PLLC
AqueSys Microfistula Implant in Refractory Glaucoma
Fayetteville :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Rogers : VoldVision-Holf Eye Clinic
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Springdale : Vold Vision
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Springdale : Vold Vision
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
View More »
Springdale :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Springdale : Vold Vision, PLLC
SOLX Gold Shunt for Refractory Glaucoma
California
Artesia : Kenneth Sall, M.D. Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Artesia : Artesia Clinical Site - Site 02
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Costa Mesa : Costa Mesa Clinical Site
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Inglewood : United Medical Research Institute Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Inglewood : Inglewood Clinical Site - Site 03
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
View More »
Irvine : University of California, Irvine
SOLX Gold Shunt for Refractory Glaucoma
La Jolla : University of California San Diego
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
La Jolla : Hamilton Glaucoma Center, UCSD
STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk (STARFISH)
Los Angeles : Doheny Eye Institute, University of Southern California
AqueSys Microfistula Implant in Refractory Glaucoma
Newport Beach : Aesthetic Eye Care Institute Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Newport Beach : Newport Beach (satellite site)
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Orange :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Palo Alto : Stanford Eye Institute
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Petaluma : Bacharach practice Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Petaluma : North Bay Eye Associates
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Petaluma : North Bay Eye Associates
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Petaluma : Petaluma Clinical Site - Site 05
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Poway : Centre For Health Care Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Sacramento :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
San Diego : Scripps Clinic
AqueSys Microfistula Implant in Refractory Glaucoma
San Diego :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
San Francisco : Glaucoma Center of San Francisco
AqueSys Microfistula Implant in Refractory Glaucoma
San Francisco : Glaucoma Center of San Francisco
The Efficacy of Selective Laser Trabeculoplasty
Santa Ana : Santa Ana (satellite site)
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Santa Rosa : North Bay Eye Associates
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Colorado
Aurora : Rocky Mountain Lions Eye Institute
Use of Ranibizumab With Mitomycin C During Trabeculectomy
Denver :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Fort Collins :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Ft. Collins :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Parker : Glaucoma Consultants of Colorado, DBA Specialty Eye
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
View More »
Parker :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Connecticut
Fairfield : Ophthalmic Consultants of Connecticut
AqueSys Microfistula Implant in Refractory Glaucoma
Fairfield : Ophthalmic Consultants of Connecticut
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
New Haven : Yale Eye Center
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
New Haven : Yale Eye Center, Yale University
Instrument for Glaucoma Early Detection and Monitoring
New Haven : New Haven Clinical Site - Site 01
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
View More »
New Haven : Yale University
SOLX Gold Shunt for Refractory Glaucoma
Florida
Boynton Beach :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Cape Coral : Farrell Tyson, MBA
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Cape Coral : Cape Coral Eye Center
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Ft. Myers :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Miami : Bascom Palmer Eye Institute, University of Miami
AqueSys Microfistula Implant in Refractory Glaucoma
View More »
Miami : Bascom Palmer Eye Institute
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Miami : Center for Excellence in Eye Care
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Miami : Center for Excellence in Eye Care
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Miami : Bascom Palmer Eye Institute
Primary Tube Versus Trabeculectomy Study
Tampa : International Eye Center
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Tampa : International Eye Center
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Georgia
Atlanta : Atlanta Clinical Site - Site 04
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Atlanta :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Augusta : Medical College of Georgia Health Inc
Effects of Xal-Ease on Patient Compliance With Xalatan
Morrow : Clayton Eye Center Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Morrow : Eye Care Centers Management/Clayton Eye Center
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
View More »
Roswell : Coastal Research Associates, LLC Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Illinois
Chicago : Northwestern Memorial Hospital
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Chicago : Chicago Eye Specialists
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Chicago : Illinois Eye Institute
SOLX Gold Shunt for Refractory Glaucoma
Iowa
Sioux City :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Sioux City :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Kansas
Garden City :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Overland Park : Stiles Eyecare Excellence and Glaucoma Institute
AqueSys Microfistula Implant in Refractory Glaucoma
Overland Park : Michael Stiles, MD
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Shawnee Mission : Bradley Kwapiszeski, MD Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Kentucky
Lexington : Univ of Ky
Safety Study of Latanoprost Slow Release Insert
Lexington : University of Kentucky
Safety Study of Latanoprost Slow Release Insert
Louisville : Taustine Eye Center Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Maryland
Baltimore : Alan L Robin, M.D. Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Baltimore : Glaucoma Specialists
Observational Study of How Patients Take Eye Drops
Havre de Grace : Seidenberg Protzko Eye Associates Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Massachusetts
Boston : Massachusetts Eye and Ear Infirmary
AqueSys Microfistula Implant in Refractory Glaucoma
Boston : Massachusetts Eye and Ear Infirmary
Effects of Anti-Glaucoma Medications on the Ocular Surface
Boston :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Lancaster : D'Ambrosio Eye Care
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Reading : Advanced Glaucoma Specialist
Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.
Michigan
Ann Arbor : W.K. Kellogg Eye Center
Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions
Detroit : Kresge Eye Institute
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
St Joseph : Great Lakes Eye Care Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Minnesota
Bloomington : Minnesota Eye Consultants, PA
AqueSys Microfistula Implant in Refractory Glaucoma
Bloomington : Minnesota Eye Consultants
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Missouri
Independence : Discover Vision Centers
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Kansas City : Silverstein Eye Centers
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Springfield : St. John's Medical Research Institute
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
St. Louis :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
New Jersey
Newark : Institue of Ophthalmology and Visual Science
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Raritan : Synabridge Corp.
Instrument for Glaucoma Early Detection and Monitoring
Vineland :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Woodland Park : Brar-Parekh Eye Associates
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
New York
Bronx : Biomedical Research Alliance of New York
Glaucoma
View More »
Bronx :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
New York : Glaucoma Associates of New York
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
New York : New York Eye and Ear Infirmary
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
New York : New York Eye and Ear Infirmary
Primary Tube Versus Trabeculectomy Study
New York : Glaucoma Associates of New York
Treatment of Failing Blebs With Ranibizumab
Rochester : Rochester Ophthalmological Group Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Rochester : Bausch & Lomb Inc.
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Rochester : Bausch & Lomb Inc.
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Rochester :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Slingerlands : Glaucoma Consultants of the Capital Region
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
North Carolina
Belmont : Charlotte Eye Ear Nose & Throat Associates, P.A. Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
High Point : High Point Clinical Site - Site 06
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Ohio
Cincinnati :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Oklahoma
Oklahoma City : Dean McGee Eye Institue
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Oklahoma City : Dean McGee Eye Institute
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Oklahoma City :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Tulsa : The Eye Institute Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Pennsylvania
Bala Cynwyd : Ophthalmic Partners of Pennsylvania
SOLX Gold Shunt for Refractory Glaucoma
Kingston :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Philadelphia : Wills Eye Institute
AqueSys Microfistula Implant in Refractory Glaucoma
Philadelphia : Wills Eye Institue
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Philadelphia : Wills Eye Institute
How Has Glaucoma Affected Your Quality of Life?
View More »
Philadelphia : University of Pennsylvania
Primary Tube Versus Trabeculectomy Study
Philadelphia : Wills Eye Institute
Spaeth/Richman Contrast Sensitivity Test
Pittsburgh :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
South Carolina
Mt. Pleasant : Carolina Eyecare Physicians
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Spartanburg : Eastside Westside Research Center
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
South Dakota
Sioux Falls : Vance Thompson Vision/Sanford Health-USD
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
Sioux Falls : Vance Thompson Vision/Sanford Health-USD
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Tennessee
Knoxville :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Maryville : University Eye Surgeons
SOLX Gold Shunt for Refractory Glaucoma
Memphis : Hamilton Eye Institute, The University of Tennessee
Instrument for Glaucoma Early Detection and Monitoring
Nashville : Vanderbilt Eye Institute
AqueSys Microfistula Implant in Refractory Glaucoma
Nashville :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Texas
Austin : Texan Eye Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Austin : Texan Eye
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Austin :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Dallas : Glaucoma Associates of Texas
AqueSys Microfistula Implant in Refractory Glaucoma
Dallas : Glaucoma Associates of Texas
Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
View More »
Dallas : Glaucoma Associates of Texas
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Dallas :
Safety & Effectiveness Study of the Hydrus Device for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
Dallas : Glaucoma Associates of Texas
SOLX Gold Shunt for Refractory Glaucoma
Dallas/Ft. Worth :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Fort Worth : Contact Alcon Call Center for Trial Locations
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Latin America
Fort Worth : Contact Alcon Call Center for Trial Locations
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Fort Worth : Contact Alcon Call Center for Trial Locations
Efficacy of Changing to Travatan From Prior Therapy
Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
Fort Worth : Contact Alcon Call Center
Safety and Efficacy of Adding Azarga Adjunctive to Prostaglandin Therapy
Fort Worth : Contact the Alcon Call Center
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Houston : University of Texas, Houston
Primary Tube Versus Trabeculectomy Study
San Antonio : Medical Center Ophth. Associates Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
San Antonio :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Utah
Salt Lake City : Stacy R. Smith, M.D. Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Salt Lake City : Utah Eye Institute
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
Virginia
Charlottesville : University of Virginia
AqueSys Microfistula Implant in Refractory Glaucoma
Charlottesville : University of Virginia
Primary Tube Versus Trabeculectomy Study
Charlottsville : University of Virginia
SOLX Gold Shunt for Refractory Glaucoma
Norfolk : Virginia Eye Consultants Updated
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
Washington
Spokane : Spokane Eye Clinic
AqueSys Microfistula Implant in Refractory Glaucoma
Spokane : Spokane Eye Clinic
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
Wenatchee :
Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Wisconsin
Green Bay : Memmen, Ltd
SOLX Gold Shunt for Refractory Glaucoma
Armenia
Yerevan : S.V. Malayan Ophthalmology Centre
A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent
Yerevan : S.V. Malayan Ophthalmological Center
Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
Yerevan : S.V. Malayan's Ophthalmology Centre
Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
Yerevan : S.V. Malayan Ophthalmological Center
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Australia
Fitzroy :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Austria
Vienna :
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Belgium
Brazil
Campinas : University of Campinas
SOLX Gold Shunt for Refractory Glaucoma
São Paulo :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Canada
Halifax : Dalhousie University
Optical Coherence Tomography (OCT) Data Collection Study
London : Ivey Eye Institute
Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
Mississauga : Credit Valley Eye Care
Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves
Mississauga : Credit Valley Eyecare / Osler Eyecare
SOLX Gold Shunt for Refractory Glaucoma
Montreal : Bellevue Ophthalmology Clinic
SOLX Gold Shunt for Refractory Glaucoma
View More »
Ontario : Contact Alcon Call Center for Trial Locations
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
Toronto : Department of Ophthalmology and Visual Sciences; Toronto Western Hospital
Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide
Toronto : Toronto Western Hospital
The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma
Vancouver :
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
Vaughan :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Vaughan : Clarity Eye Institute
SOLX Gold Shunt for Refractory Glaucoma
Waterloo : Centre for Contact Lens Research, University of Waterloo
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
China
Beijing :
A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension
Shanghai : Shanghai sixth People's Hospital
Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital
Colombia
Bogotá :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Czech Republic
Brno : Fakultni nemocnice Brno
Long-Term Non-Interventional Latanoprost Study
Praha 5 : Fakultni nemocnice v Motole
Long-Term Non-Interventional Latanoprost Study
Denmark
Glostrup : Glostrup Hospital, Oegenafdelingen
Long-Term Non-Interventional Latanoprost Study
Estonia
Tallin : East Tallin Central Hospital
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Tallin : Eye Clinic Dr. Krista Turman
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Tartu : Tartu University Clinics
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
Finland
Kuopio : Eye clinic, University Hospital of Kuopio
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
Tampere : FinnMedi Oy, Clinical Trial Center
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
France
Amiens :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
Amiens : CHU d'Amiens -Centre Saint Victor
Long-Term Non-Interventional Latanoprost Study
Dijon : University Hospital
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
Dijon : University Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Grenoble : Michallon University Hospital
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
View More »
Grenoble : University Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Lille : Huriez University Hospital
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
Lille : University Hospital - Cl Huriez
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Lille Cedex : Hopital Claude Huriez
Long-Term Non-Interventional Latanoprost Study
Lyon : Croix Rousse University Hospital
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
Lyon : Clinique du Parc - Private Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Lyon : Croix Rousse Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Lyon :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Paris : HIA - Val de Grace Hospital
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
Paris : Val de Grace Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Paris : XV-XX National Ophthalmologic Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Paris : Saint-Joseph Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Paris : XV-XX Ophthalmologic Hospital
Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device
Paris : Centre Hospitalier National d'Ophthalmologie des Quinze-Vingts
IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty
Paris : Centre Hospitalier National d'Opthalmology des Quinze-Vingts
IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy
Germany
Berlin : Parexel International GmbH, Early Phase Clinical Unit
Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
Cologne : The University Hospital of Cologne
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany
Cologne : Centre of Ophthalmology, University of Cologne
Trabeculectomy Versus Canaloplasty to Treat Glaucoma
Dresden :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Freiburg : Universitaetsklinikum Freiburg
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
View More »
Giessen : Universitaetsklinikum Giessen
Long-Term Non-Interventional Latanoprost Study
Hamburg : Universitaetsklinikum Hamburg-Eppendorf
Long-Term Non-Interventional Latanoprost Study
Koln : Hospital of Universität Köln
Oculusgen (Ologen) Collagen Matrix Safety and Effective Comparision With MMC in Glaucoma Surgery
Köln : Uniklinik Köln
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Mainz : Universitaetsklinikum Mainz
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Mainz : Universitaetsklinikum Mainz
Long-Term Non-Interventional Latanoprost Study
Mainz :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Tübingen : Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen
Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)
Tuebingen : Centre for Ophthalmology, Institute for Ophthalmic Research
Comparison of Visual Fields: Humphrey Field Analyzer (HFA) SITA Strategy, SCOPE (GATE Strategy) and Humphrey MATRIX Perimeter
Tuebingen : Institute for Ophthalmic Research
Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients
Greece
India
Gurgaon : MSD Pharmaceuticals Pvt. Ltd
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002 AM1)
Hyderabad : L. V. Prasad Eye Institute
Ologen (OculusGen)-Glaucoma Case Control Trial in India
Hyderabad : L. V. Prasad Eye Institute
Ologen (OculusGen)-Glaucoma MMC Control Trial in India
Israel
Haifa : Bnei Zion Medical Center
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Petach Tikva :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Tel Aviv :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Tel-Hashomer : Medical Research Infrastructure Department and Health Services Fund by the Sheba Medical Center (R.A.)
SOLX Gold Shunt for Refractory Glaucoma
Italy
Catania : Azienda Ospedaliero Univ.
Long-Term Non-Interventional Latanoprost Study
Fiumicino (Roma) : Ospedale Pediatrico Bambino Gesu
Long-Term Non-Interventional Latanoprost Study
Genova : Istituto Giannina Gaslini, Divisione di Oculistica
Long-Term Non-Interventional Latanoprost Study
Milan :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
Milano : Unita' Operativa di Oculistica Pediatrica, Azienda Ospedaliera Ospedale Niguarda Ca'Grande
Long-Term Non-Interventional Latanoprost Study
View More »
Milano :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Parma :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
Korea, Republic of
Seoul :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
Mexico
Mexico City :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Netherlands
Amsterdam :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Peru
Miraflores : Óptima Visión
Long-Term Non-Interventional Latanoprost Study
Poland
Gdańsk :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Poznan : Przemienienia Pańskiego Hospital, Poznan University of Medical Sciences Karol Marcinkowski
Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG
Portugal
Singapore
Singapore : Singapore Eye Research Institute
Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study
Slovakia
Spain
Barcelona : Institut Català de Retina
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Esplugues de Llobregat : Hospital Sant Joan de Deu
Long-Term Non-Interventional Latanoprost Study
Madrid : Hospital Universitario 12 de Octubre
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario Ramón y Cajal
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario Clínico San Carlos
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
View More »
Madrid : Hospital Clinico San Carlos
Long-Term Non-Interventional Latanoprost Study
Pamplona : Clinica Universidad Navarra
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Sevilla : Hospital Virgen Del Rocio
Long-Term Non-Interventional Latanoprost Study
Torrevieja :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Valladolid : Instituto de Oftalmobiología Aplicada
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Zaragoza : Hospital Universitario Miguel Servet
Long-Term Non-Interventional Latanoprost Study
Sweden
Uppsala : Akademiska Sjukhuset
Long-Term Non-Interventional Latanoprost Study
Vasteras : Ogonkliniken, Centrallasarett
Long-Term Non-Interventional Latanoprost Study
Taiwan
Taipei :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
United Kingdom
Birmingham : Birmingham and Midland Eye Centre, Consultant Ophthalmologist
Long-Term Non-Interventional Latanoprost Study
London :
A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
London : Richard Desmond Childrens Eye Centre
Long-Term Non-Interventional Latanoprost Study
London : Moorfields Eye Hospital NHSFT Research and Treatment Centre
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
